[Federal Register Volume 63, Number 112 (Thursday, June 11, 1998)]
[Notices]
[Pages 31998-32000]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-15540]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Announcement Number 98065]
Grant to Study a Healthy Home/Healthy Community Intervention
Notice of Availability of Funds for Fiscal Year 1998
A. Purpose
The Centers for Disease Control and Prevention (CDC) announces the
availability of fiscal year (FY) 1998 funds for a grant to evaluate the
effectiveness of a Healthy Homes/Healthy Community intervention to
improve children's health by addressing environmental hazards in
deteriorating communities and inadequate housing. This program
addresses the Healthy People 2000 priority areas of Environmental
Health, Educational and Community-Based Programs, and Maternal and
Infant Health.
The purpose of this program is the implementation and evaluation of
an intervention strategy in a target neighborhood to prevent childhood
disease caused by health hazards in the residential environment. This
intervention will be to bring to bear private- and public-sector
financing to reduce multiple environmental hazards and associated
childhood morbidities at the level of both individual home and
surrounding neighborhood.
B. Eligible Applicants
Applications may be submitted by public and private nonprofit
organizations and by governments and their agencies; that is
universities, colleges, research institutions, hospitals, other public
and private nonprofit organizations, State and local governments or
their bona fide agent.
Note: Public Law 104-65 states that an organization described in
section 501(c)(4) of the Internal Revenue Code of 1986 that
[[Page 31999]]
engages in lobbying activities is not eligible to receive Federal
funds constituting an award, grant, cooperative agreement, contract,
loan, or any other form.
C. Availability of Funds
Approximately $100,000 is available in FY 1998 to fund 1 award. It
is expected that the award will begin on or about September 30, 1998,
and will be made for a 12-month budget period within a project period
of up to 3 years. Funding estimates may change.
Use of Funds
Applicants may enter into contracts and consortia
agreements and understandings as necessary to meet the requirements of
the program and strengthen the overall application.
Grants funds may not be expended for medical care and
treatment or for environmental remediation.
D. Cooperative Activities
The following are applicant requirements:
1. A director with specific authority and responsibility to carry
out the requirements of the project and has demonstrated experience in
conducting relevant epidemiologic studies, including publication of
original research in peer-reviewed journals.
2. Design, implement and evaluate a single strategy intervention
which may be based on the Community Reinvestment Act (CRA), a Federal
law requiring federally insured deposit facilities (e.g. banks and
thrift-deposit agencies) to respond to identified credit needs in low-
income communities that they serve. (To obtain information on CRA see
WHERE TO OBTAIN ADDITIONAL INFORMATION.)
3. Evaluate and interpret the outcome of the intervention,
including, collecting and analyzing data necessary to enable
measurement of these outcomes.
4. Disseminate research findings.
E. Application Content
Use the information in the COOPERATIVE ACTIVITIES, OTHER
REQUIREMENTS, and EVALUATION CRITERIA sections to develop the
application content. Your application will be evaluated on the criteria
listed, so it is important to follow them in laying out your program
plan. The narrative should be no more than 30 double-spaced pages,
printed on one side, with one inch margins, and unreduced font.
Please prepare your application following the instructions in the
PHS Form 398. The following are requirements:
1. Research and intervention plan including: The proposed
activities should be clearly described in terms of need, scientific
basis, target neighborhood, financial institution participation,
expected interactions, and anticipated outcomes.
2. A research plan (design and methods) including hypothesis and
expected outcome, value to field, and specific, measurable, and time-
framed objectives consistent with the proposed intervention strategy.
The applicant must demonstrate that they have met the CDC/ATSDR policy
requirements regarding the inclusion of women, ethnic, and racial
groups in the proposed projects. This includes:
a. The proposed plan for the inclusion of both sexes and racial and
ethnic minority populations for appropriate representation;
b. The proposed justification when representation is limited or
absent;
c. A statement as to whether the design of the study is adequate to
measure differences when warranted; and
d. A statement as to whether the plans for recruitment and outreach
for study participants include the process of establishing partnerships
with community(ies) and recognition of mutual benefits.
Human Subjects: If the proposed research involves obtaining data
through intervention or interaction with an individual(s) or
identifiable private information, then the applicant must provide
background information on the precautions that will be put in place to
protect human subjects.
3. Plans to collect baseline and post-intervention measures of
environmental hazards, for example, the number of residential units in
a defined neighborhood with specified hazards.
4. Plans to collect baseline and post-intervention measures of
specified health effects among children (e.g., hospital admissions for
asthma or specified injuries, reports of rat bites, elevated blood lead
levels, pesticide or other household poisonings).
5. Evidence of effective and well-defined working relationships
within the performing organization and with outside entities which will
ensure implementation of the proposed study.
6. Evidence of access to a laboratory with necessary proficiency in
performing environmental and biologic laboratory measurements as
required by the proposed study protocol.
7. Plans to ensure that children identified with health conditions
associated with environmental hazards are referred for appropriate
medical and environmental management. If the applicant does not have
direct responsibility for such activities, a letter of support from the
organization with that responsibility is required.
8. Evidence of ability to identify and gain access to a
neighborhood with demonstrated environmental hazards and associated
childhood morbidities among residents, and to collect appropriate
environmental and biologic data.
9. Evidence that a deposit facility (bank or thrift) that is
subject to the provisions of the Community Reinvestment Act has agreed
to participate in the intervention strategy.
F. Application Submission and Deadline
Submit the original and five copies of PHS Form 398 (Revised 5/95,
OMB Control Number 0925-0001) (adhere to the instructions on the Errata
Instruction Sheet for PHS Form 398). Forms are in the application kit.
On or before August 10, 1998, submit the application to: Lisa T.
Garbarino, Grants Management Specialist, Grants Management Branch,
Procurement and Grants Office, Announcement Number 98065, Centers for
Disease Control and Prevention (CDC), 255 East Paces Ferry Road, NE.,
Room 300, Mailstop E-13, Atlanta, Georgia 30305-2209.
If your application does not arrive in time for submission to the
independent review group, it will not be considered in the current
competition unless you can provide proof that you mailed it on or
before the deadline (i.e., a legibly dated receipt from U.S. Postal
Service or a commercial carrier; private metered postmarks are not
acceptable).
G. Evaluation Criteria
Each application will be evaluated individually against the
following criteria by an independent review group appointed by CDC.
1. Research and Intervention Plan (50 Points)
a. Description of the intervention strategy and how it will be
implemented that is sufficient to enable replication of the
intervention.
b. Evaluation plans; scientific soundness (including description of
both hazard and health-effect outcomes to be measured, adequate sample
size with power calculations), quality, feasibility, consistency with
the project goals.
c. Access to suitable target neighborhood and cooperation of a
financial institution.
2. Environmental, Educational, and Medical Intervention (15 Points)
Ability to provide appropriate referral for children identified as
having the
[[Page 32000]]
environmental exposures specified in the intervention.
3. Project Personnel (15 Points)
The qualifications, experience, (including experience in conducting
relevant studies) and time commitment of the staff needed to ensure
implementation of the project.
4. Laboratory Capacity (10 Points)
Documented availability of a laboratory with demonstrated
proficiency in performing laboratory measurements as indicated in
applicant's proposed study.
5. Performance Measurement (10 Points)
Schedule for implementing and monitoring the project. The extent to
which the application documents specific, attainable, and realistic
goals and clearly indicates the performance measures that will be
monitored, how they will be monitored, and with what frequency.
6. Budget and Justification (Not Scored)
The budget will be evaluated for the extent to which it is
reasonable, clearly justified, and consistent with the intended use of
cooperative agreement funds.
7. Human Subjects (Not Scored)
If human subjects will be involved, how will they be protected,
i.e., describe the review process which will govern their
participation. The applicant must demonstrate that they have met the
CDC Policy requirements regarding the inclusion of women, ethnic, and
racial groups in the proposed research. This includes:
a. The proposed plan for the inclusion of both sexes and racial and
ethnic minority populations for appropriate representation;
b. The proposed justification when representation is limited or
absent;
c. A statement as to whether the design of the study is adequate to
measure differences when warranted; and
d. A statement as to whether the plans for recruitment and outreach
for study participants include the process of establishing partnerships
with community(ies) and recognition of mutual benefits.
H. Other Requirements
Technical Reporting Requirements Provide CDC with the original plus
two copies of
1. Annual progress reports including the following for each goal or
activity involved in the study:
a. a comparison of actual accomplishments to the goals established
for the period;
b. the reasons for slippage if established goals were not met; and
c. other pertinent information and data essential to evaluating
progress.
2. Financial status report, no more than 90 days after the end of
the budget period, and
3. Final financial report and performance report no more than 90
days after the end of the project period.
Send all reports to: Lisa T. Garbarino, Grants Management
Specialist, Grants Management Branch, Procurement and Grants Office,
Centers for Disease Control and Prevention, (CDC), 255 East Paces Ferry
Road, NE., Room 300, Mailstop E-13, Atlanta, Georgia 30305-2209.
The following additional requirements are applicable to this
program. For a complete description of each, see Addendum 1 (included
in the application kit).
AR98-1 Human Subjects Requirements
AR98-2 Requirements for Inclusion of Women and Racial and Ethnic
Minorities in Research
AR98-9 Paperwork Reduction Act Requirements
AR98-10 Smoke-Free Workplace Requirements
AR98-11 Healthy People 2000
AR98-12 Lobbying Restrictions
I. Authority and Catalog of Federal Domestic Assistance Number
This program is authorized under the Public Health Service Act,
Section 301(a) [42 U.S.C. section 241(a)], as amended. The Catalog of
Federal Domestic Assistance number is 93.197.
J. Where To Obtain Additional Information
To receive additional written information call 1-888-GRANTS4 (1-
888-472-6874). You will be asked to leave your name, organization,
address, and phone number and will need Announcement Number 98065. All
application procedures and guidelines are contained within that package
or can be found on the CDC Home Page. The address for the CDC Home Page
is [http://www.cdc.gov].
Business management technical assistance, contact: Lisa T.
Garbarino, Grants Management Specialist, Grants Management Branch,
Procurement and Grants Office, Announcement Number 98065, Centers for
Disease Control and Prevention, (CDC), 255 East Paces Ferry Road, NE.,
Room 300, Mailstop E-13, Atlanta, Georgia 30305-2209, Telephone: (404)
842-6796, E-mail address: lgt1@cdc.gov.
For program technical assistance, contact: Nancy Tips, National
Center for Environmental Health, Division of Environmental Hazards and
Health Effects, Centers for Disease Control and Prevention (CDC), 4770
Buford Highway, NE., Room 1320, Mailstop F-42, Atlanta, Georgia 30341,
Telephone: (770) 488-7277, E-mail address: nmt1@cdc.gov.
To receive the document Innovative Financing Sources for Lead
Hazard Control published by the Alliance to End Childhood Lead
Poisoning, or the booklet on Community Reinvestment Act (CRA), contact
Nancy Tips. (Address and number above.)
Joseph R. Carter,
Acting Associate Director for Management and Operations, Centers for
Disease Control and Prevention (CDC).
[FR Doc. 98-15540 Filed 6-10-98; 8:45 am]
BILLING CODE 4163-18-P
